Trial NCT03693573

View at ClinicalTrials.gov 
Org. Study IDs: MO39939

Last trial update was posted on 2018-11-15

MeSH Interventions

Atezolizumab Bevacizumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Renal Cell Carcinoma

Stopping Reasons

In the context of the ongoing evaluation of our data, we have determined that there is no need to generate additional safety data at this time in the 1L mRCC pa

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID